Holen Sie sich die Stockscreener-App
556.20
2.18%
11.88
Vorhandelsmarkt:
564.45
8.25
+1.48%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
IDEXX Laboratories Inc (IDXX) Balance Sheet - TradingKey
Here's How IDEXX Laboratories Is Placed Ahead of Q2 Earnings - Yahoo Finance UK
IDEXX Laboratories (IDXX) Looks Attractive on Recurring Revenue and High Customer Retention - Yahoo Finance
IDXX|IDEXX Laboratories Inc|Price:544.320|Chg%:+4.955 - TradingKey
IDEXX Laboratories stock holds firm on recurring diagnostics demand - Ad-hoc-news.de
IDEXX Laboratories, Inc. Revenue Breakdown – NASDAQ:IDXX - TradingView
IDEXX Laboratories stock trades near record levels as diagnostics growth supports valuation - Ad-hoc-news.de
TradingKey - TradingKey
IDEXX Laboratories Inc (IDXX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IDEXX Laboratories Inc (IDXX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IDEXX Laboratories Inc (IDXX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IDEXX Laboratories, Inc. (IDXX) Stock Price, News, Quote & History - Yahoo! Finance Canada
IDEXX Laboratories Inc (IDXX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IDEXX Laboratories Inc (IDXX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - 富途牛牛
IDXX|IDEXX Laboratories Inc|Price:556.100|Chg%:+11.780 - TradingKey
IDEXX Laboratories stock trades near record levels as recurring diagnostics revenue supports valuati - Ad-hoc-news.de
IDEXX Laboratories Inc (IDXX) Valuation: PE, PB & Fair Value Analysis - TradingKey
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
Idexx Could Feel Chill as Pet Owners Face Rising Cost of Living - Morningstar
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IDEXX stock trades near record territory as recurring diagnostics revenue supports double digit grow - AD HOC NEWS
IDXX: Idexx Laboratories Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
IDEXX Laboratories stock holds steady as earnings metrics shape the outlook - AD HOC NEWS
IDXX|IDEXX Laboratories Inc|Price:539.180|Chg%:-0.185 - TradingKey
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IDEXX Laboratories stock trades near record range as recurring veterinary revenue supports margins - AD HOC NEWS
IDEXX Laboratories stock stays anchored to its diagnostics growth - Ad-hoc-news.de
IDEXX Laboratories, Inc. (IDXX): Investor Outlook Reveals 24.85% Potential Upside in the Diagnostics Sector - DirectorsTalk Interviews
IDEXX Laboratories stock trades near record levels as veterinary diagnostics growth supports valuati - Ad-hoc-news.de
IDEXX Laboratories earnings preview: What to expect - MSN
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
New diagnostic test for kidney injury - DVM360
Global Livestock Monitoring Market to Reach $10.3 Billion by 2030, Driven by Digital Agriculture Transformation - GlobeNewswire Inc.
IDEXX Laboratories stock trades near record levels as companion animal diagnostics drive growth - Ad-hoc-news.de
IDEXX Laboratories (IDXX) Could Be 19% Undervalued After Stifel Flags Better Pet Health Trends - Sahm
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Idexx Laboratories (IDXX) Shows Promising Growth Potential - GuruFocus
Is IDEXX Laboratories Inc (IDXX) a Bargain After 4.2% Drop? GF V - GuruFocus
Why IDEXX Laboratories (IDXX) Stock Is Down Today - Moomoo
Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating - Moomoo
Donald TrumpIDEXX LABS UNSOLICITED Trump Trade on Mar. 23, 2026 - Quiver Quantitative
IDEXX Laboratories stock holds steady as diagnostics demand supports long-term growth - ad-hoc-news.de
IDEXX Laboratories Earnings Preview: What to Expect - Barchart.com
IDEXX Laboratories focuses on diagnostics growth. Investors watch demand trends - ad-hoc-news.de
IDEXX Laboratories extends its diagnostics reach as a key S&P 500 health-tech name - ad-hoc-news.de
IDEXX Laboratories Does Not Need More Vet Visits, But It Needs More Tests Per Visit (IDXX) - Seeking Alpha
William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating - Moomoo
IDEXX Laboratories focuses on diagnostics growth. Business model supports long-term demand - ad-hoc-news.de
IDEXX Laboratories Stock: $876 Target Backed by Cancer Dx Adoption Across 7,500 Practices - TIKR.com
IDEXX Laboratories stock holds its focus on diagnostics. Investors watch the business mix. - AD HOC NEWS
IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a Potential 27% Upside for Investors - DirectorsTalk Interviews
The SNAP Pro AnalyzerIDEXX Laboratories leans on faster point-of-care diagnostics - ad-hoc-news.de
IDEXX Laboratories stock tracks its core diagnostics business - ad-hoc-news.de
IDXXIdexx Laboratories Inc Volatility & Greeks - Finviz
Enterprise value to EBIT forward of IDEXX Laboratories, Inc. – NASDAQ:IDXX - TradingView
IDEXX Laboratories stock leans on its diagnostics base - Ad-hoc-news.de
IDEXX Laboratories focuses on diagnostics growth as investors watch long-term demand - ad-hoc-news.de
0.49%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):